| CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation |
22 |
| CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses |
17 |
| Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction |
17 |
| Neurosurgical applications of MRI guided laser interstitial thermal therapy (LITT) |
16 |
| Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI |
15 |
| Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases |
14 |
| CT texture analysis: a potential tool for predicting the Fuhrman grade of clear-cell renal carcinoma |
13 |
| Most-enhancing tumor volume by MRI radiomics predicts recurrence-free survival early on in neoadjuvant treatment of breast cancer |
12 |
| Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram |
11 |
| MRI features of combined hepatocellular-cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma |
10 |
| Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling |
10 |
| CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis |
10 |
| Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experience |
10 |
| The utility of MRI histogram and texture analysis for the prediction of histological diagnosis in head and neck malignancies |
10 |
| Radiomics models for diagnosing microvascular invasion in hepatocellular carcinoma: which model is the best model? |
10 |
| Ultrasound-guided percutaneous laser ablation for papillary thyroid microcarcinoma: a retrospective analysis of 37 patients |
9 |
| Tumor heterogeneity in gastrointestinal stromal tumors of the small bowel: volumetric CT texture analysis as a potential biomarker for risk stratification |
9 |
| The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis |
8 |
| Intra-individual comparison of Ga-68-PSMA-11 and F-18-DCFPyL normal-organ biodistribution |
8 |
| Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017) |
8 |
| 68Ga-PSMA PET/CT in prostate cancer patients - patterns of disease, benign findings and pitfalls |
8 |
| Changes in biodistribution on Ga-68-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression |
7 |
| Predicting malignant potential of subsolid nodules: can radiomics preempt longitudinal follow up CT? |
6 |
| C-11-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial) |
6 |
| Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer |
6 |
| IDEAL-IQ in an oncologic population: meeting the challenge of concomitant liver fat and liver iron |
6 |
| Prediction of high nodal burden with ultrasound and magnetic resonance imaging in clinically node-negative breast cancer patients |
6 |
| Metabolic tumor burden on postsurgical PET/CT predicts survival of patients with gastric cancer |
6 |
| Clinical impact of variability on CT radiomics and suggestions for suitable feature selection: a focus on lung cancer |
6 |
| Endometrial cancer: an overview of novelties in treatment and related imaging keypoints for local staging |
6 |
| The utility of measuring the apparent diffusion coefficient for peritumoral zone in assessing infiltration depth of endometrial cancer |
6 |
| Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer |
6 |
| Ga-68-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer |
6 |
| Accuracy and complications of CT-guided pulmonary core biopsy in small nodules: a single-center experience |
5 |
| An international survey on hybrid imaging: do technology advances preempt our training and education efforts? |
5 |
| Comparative effect of iso-osmolar versus low-osmolar contrast media on the incidence of contrast-induced acute kidney injury in diabetic patients: a systematic review and meta-analysis |
5 |
| Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers |
5 |
| Mono, bi- and tri-exponential diffusion MRI modelling for renal solid masses and comparison with histopathological findings |
5 |
| Man or machine? Prospective comparison of the version 2018 EASL, LI-RADS criteria and a radiomics model to diagnose hepatocellular carcinoma |
5 |
| CT lymphography for sentinel lymph node mapping of clinically N0 early oral cancer |
5 |
| Radiological semantics discriminate clinically significant grade prostate cancer |
5 |
| Percutaneous radiofrequency ablation of adrenal metastases from hepatocellular carcinoma: a single-center experience |
5 |
| The eye of the beholder: orbital metastases from midgut neuroendocrine tumors, a two institution experience |
5 |
| Comparative analysis of the value of diffusion kurtosis imaging and diffusion-weighted imaging in evaluating the histological features of endometrial cancer |
5 |
| F-18-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma |
4 |
| Application of magnetic resonance diffusion kurtosis imaging for distinguishing histopathologic subtypes and grades of rectal carcinoma |
4 |
| Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT |
4 |
| Whole-body magnetic resonance imaging of Li-Fraumeni syndrome patients: observations from a two rounds screening of Brazilian patients |
4 |
| Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules |
4 |
| Imaging and clinical features of Castleman Disease |
4 |
